Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2021-04-25 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
长城证券股份有限公司关于浙江泰林生物技术股份有限公司2020年度内部控制评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed internal control evaluation report for the year 2020 of Zhejiang Tailin Biotechnology Co., Ltd., prepared and reviewed by Great Wall Securities Co., Ltd. It includes comprehensive descriptions of internal control scope, governance structure, financial reporting controls, risk management, and audit committee oversight. The document is not a full annual report but a specific internal control evaluation report with detailed findings and conclusions on internal control effectiveness. It is not an announcement or a brief summary but a substantive report with detailed content. This fits the definition of an Audit Report / Information (AR), which includes internal control evaluation reports and audit-related information separate from full annual reports. The document length (9833 characters) and content confirm it is a full report, not just an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2020
2021-04-25 Chinese
独立董事关于第三届董事会第一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion report from the independent directors of Zhejiang Tailin Biotechnology Co., Ltd. regarding matters discussed at the first meeting of the third board of directors. It covers opinions on the 2020 profit distribution plan, reappointment of the audit firm for 2021, internal control self-evaluation report for 2020, remuneration plans for 2021, appointment of senior management, and other governance-related issues. The document is not a full annual report or audit report but rather an independent directors' opinion on board meeting matters, including audit and governance topics. It is not a short announcement but a detailed opinion document related to board/management information and governance. Therefore, the best fitting category is Board/Management Information (MANG). The document length is 2475 characters, which is relatively short but contains substantive content related to board decisions and opinions, not just an announcement or certification. Hence, it is not RNS or RPA.
2021-04-25 Chinese
独立董事2020年度述职报告（黄文礼）
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director of Zhejiang Tailin Biotechnology Co., Ltd. It covers the director's attendance at meetings, opinions on company matters, inspections, committee work, investor protection efforts, and plans for the next year. It is a narrative report on governance and oversight activities rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it a brief announcement or certification. The content aligns with a Management Report or similar governance-related disclosure. Given the focus on the independent director's duties and governance, the best fitting category is Board/Management Information (MANG). The document length is under 5,000 characters, but it is a substantive report, not a mere announcement, so it is not RPA or RNS.
2021-04-25 Chinese
2020年度总经理工作报告
Management Reports Classification · 95% confidence The document is titled '2020 年度总经理工作报告' which translates to '2020 Annual General Manager Work Report'. It contains a detailed narrative of the company's performance, achievements, R&D, marketing, production, quality management, governance, social responsibility, and future plans for the year 2020 and beyond. It includes financial figures such as revenue and net profit for the year 2020, as well as strategic goals for 2021 and beyond. The document is comprehensive and covers management's explanation of financial results, business trends, and outlook. It is not a brief announcement or a certification, nor is it a transcript or a presentation. The length (6402 characters) and content indicate it is a management report rather than a full annual report (10-K) or interim report. Given the detailed management discussion and analysis style, the best fitting category is Management Reports (MDA).
2021-04-25 Chinese
2020年度监事会工作报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2020年度监事工作报告" which translates to "2020 Supervisory Board Work Report". It details the supervisory board's activities, oversight of financial conditions, internal controls, compliance with laws and regulations, and review of the 2020 annual report. The document is a report from the supervisory board on their work during the year 2020, including their audit and supervisory activities, but it is not the full annual report itself. It is a standalone supervisory report related to the audit and governance oversight of the company for the year 2020. The length is 3716 characters, which is relatively short and consistent with a supervisory or audit report rather than a full annual report. The content focuses on supervisory activities, financial oversight, internal control evaluation, and compliance, which aligns with an Audit Report / Information filing rather than an Annual Report (10-K) or Management Report (MDA). Therefore, the best classification is Audit Report / Information (AR). FY 2020
2021-04-25 Chinese
关于2020年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2020 annual profit distribution plan of Zhejiang Tailin Biotechnology Co., Ltd. It details the proposed cash dividend per share, the total dividend amount, and the approval process by the board of directors, supervisory board, and independent directors. It also mentions that the plan will be submitted to the 2020 annual general meeting for approval. The document is relatively short (1800 characters) and serves as a formal announcement of the dividend distribution proposal rather than the dividend payment notice itself or a full financial report. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and related details for shareholders.
2021-04-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.